Showing results (101-110 of 246) with videos related to

Sort By:
Pageof 25
Drugs|July 29, 2026
DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future PerspectivesGiovanna Pecoraro, Alberto De Giorgi, Giulia Montelatici, et al.
Neoplasia (New York, N.Y.)|November 2, 2025
A calcium-sensing MCTP1/FYN/MEF2C circuit drives therapy-induced neuroendocrine prostate cancerPhan Vu Thuy Dung, Wei-Yu Chen, Ming-Kun Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2018
Low Tristetraprolin Expression Is Associated with Lethal Prostate CancerTravis Gerke, Himisha Beltran, Xiaodong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2024
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer BiopsiesMichael C Haffner, Michael J Morris, Chien-Kuang C Ding, et al.
Nature Communications|February 20, 2026
Crosstalk between EZH2 and DNA methylation mediates neuroendocrine prostate cancer lineage plasticityRicha Singh, Varadha Balaji Venkadakrishnan, Eddie Imada, et al.
Urology|December 29, 2020
Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting SummaryMartin R Hofmann, Maha Hussain, Scott M Dehm, et al.
Nature Communications|December 11, 2024
AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patientsTodd P Knutson, Bin Luo, Anna Kobilka, et al.
JCO Precision Oncology|September 3, 2019
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden DistributionEvan M Fernandez, Kenneth Eng, Shaham Beg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2026
Molecular Characterization of KLK2 RNA Expression in Prostate CancerRana R McKay, Shayan S Nazari, Andrew Elliott, et al.
International Journal of Cancer|October 4, 2021
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patientsVincenza Conteduca, Emanuela Scarpi, Daniel Wetterskog, et al.
Pageof 25